123 related articles for article (PubMed ID: 3038999)
1. Regulation of interleukin 2 synthesis by cAMP in human T cells.
Mary D; Aussel C; Ferrua B; Fehlmann M
J Immunol; 1987 Aug; 139(4):1179-84. PubMed ID: 3038999
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
Chouaib S; Welte K; Mertelsmann R; Dupont B
J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
[TBL] [Abstract][Full Text] [Related]
3. Inhibition and activation of interleukin 2 synthesis by direct modification of guanosine triphosphate-binding proteins.
Aussel C; Mary D; Peyron JF; Pelassy C; Ferrua B; Fehlmann M
J Immunol; 1988 Jan; 140(1):215-20. PubMed ID: 2826588
[TBL] [Abstract][Full Text] [Related]
4. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.
Bartik MM; Bauman GP; Brooks WH; Roszman TL
Cell Immunol; 1994 Oct; 158(1):116-30. PubMed ID: 8087859
[TBL] [Abstract][Full Text] [Related]
5. Two differential effects of cyclic adenosine 3',5'-monophosphate on IL-5 production by antigen-specific human T cell line.
Kaminuma O; Mori A; Ogawa K; Wada K; Kikkawa H; Naito K; Suko M; Okudaira H
J Pharmacol Exp Ther; 1997 Oct; 283(1):345-9. PubMed ID: 9336342
[TBL] [Abstract][Full Text] [Related]
6. Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: effects on cyclic nucleotides, cytoplasmic free calcium, and cAMP-mediated suppression.
Ledbetter JA; Parsons M; Martin PJ; Hansen JA; Rabinovitch PS; June CH
J Immunol; 1986 Nov; 137(10):3299-305. PubMed ID: 3021852
[TBL] [Abstract][Full Text] [Related]
7. PGE2 induces IL-1beta gene expression in mouse osteoblasts through a cAMP-PKA signaling pathway.
Park YG; Kang SK; Noh SH; Park KK; Chang YC; Lee YC; Kim CH
Int Immunopharmacol; 2004 Jun; 4(6):779-89. PubMed ID: 15135319
[TBL] [Abstract][Full Text] [Related]
8. Activation of the cAMP-dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor in activated human T lymphocytes.
Borger P; Kauffman HF; Vijgen JL; Postma DS; Vellenga E
Exp Hematol; 1996 Feb; 24(2):108-15. PubMed ID: 8641331
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of lymphokine-activated killer cell differentiation and lymphocyte proliferation by stimulation of protein kinase C or inhibition of adenylate cyclase.
Beckner SK; Farrar WL
J Immunol; 1988 Jan; 140(1):208-14. PubMed ID: 2447168
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 inhibits the activation of cloned T cell hybridomas.
Makoul GT; Robinson DR; Bhalla AK; Glimcher LH
J Immunol; 1985 Apr; 134(4):2645-50. PubMed ID: 2857750
[TBL] [Abstract][Full Text] [Related]
11. Increased cyclic adenosine monophosphate levels block progression but not initiation of human T cell proliferation.
Lingk DS; Chan MA; Gelfand EW
J Immunol; 1990 Jul; 145(2):449-55. PubMed ID: 2164063
[TBL] [Abstract][Full Text] [Related]
12. Effects of anti-proliferative cyclic AMP on interleukin 2-stimulated gene expression.
Farrar WL; Evans SW; Rapp UR; Cleveland JL
J Immunol; 1987 Sep; 139(6):2075-80. PubMed ID: 3040863
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo.
Aune TM; Golden HW; McGrath KM
J Immunol; 1994 Jul; 153(2):489-98. PubMed ID: 8021490
[TBL] [Abstract][Full Text] [Related]
14. Modulation of IL-2- and IL-4-dependent human B cell proliferation by cyclic AMP.
Vazquez A; Auffredou MT; Galanaud P; Leca G
J Immunol; 1991 Jun; 146(12):4222-7. PubMed ID: 1645759
[TBL] [Abstract][Full Text] [Related]
15. Heterologous regulations of cAMP responses in pregnant rat myometrium. Evolution from a stimulatory to an inhibitory prostaglandin E2 and prostacyclin effect.
Tanfin Z; Harbon S
Mol Pharmacol; 1987 Aug; 32(1):249-57. PubMed ID: 3039339
[TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP suppresses interleukin-5 synthesis by human helper T cells via the downregulation of the calcium mobilization pathway.
Kaminuma O; Mori A; Ogawa K; Kikkawa H; Nakata A; Ikezawa K; Okudaira H
Br J Pharmacol; 1999 May; 127(2):521-9. PubMed ID: 10385254
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate.
Knudsen PJ; Dinarello CA; Strom TB
J Immunol; 1986 Nov; 137(10):3189-94. PubMed ID: 3021848
[TBL] [Abstract][Full Text] [Related]
18. Differential sensitivity to cAMP among human cord and maternal/adult peripheral lymphocytes discloses differences between PHA- and OKT3-induced activation pathways.
Papadogiannakis N; Johnsen SA; Rosberg S; Andersson RG; Olding LB
Immunology; 1989 Nov; 68(3):378-83. PubMed ID: 2556345
[TBL] [Abstract][Full Text] [Related]
19. Alterations in beta-adrenoceptor density on T-lymphocytes upon activation with interleukin-2 and phytohaemagglutinin.
Korichneva IL; Tkachuk VA
Biomed Sci; 1990 Jan; 1(1):84-8. PubMed ID: 1966667
[TBL] [Abstract][Full Text] [Related]
20. EP4/EP2 receptor-specific prostaglandin E2 regulation of interleukin-6 generation by human HSB.2 early T cells.
Zeng L; An S; Goetzl EJ
J Pharmacol Exp Ther; 1998 Sep; 286(3):1420-6. PubMed ID: 9732406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
